tiprankstipranks
Trending News
More News >
Organogenesis Holdings (ORGO)
:ORGO
US Market

Organogenesis Holdings (ORGO) Income Statement

Compare
482 Followers

Organogenesis Holdings Income Statement

Last quarter (Q3 2025), Organogenesis Holdings's total revenue was $150.86M, an increase of 30.98% from the same quarter last year. In Q3, Organogenesis Holdings's net income was $21.57M. See Organogenesis Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 482.04M$ 433.14M$ 450.89M$ 467.36M$ 338.30M
Gross Profit
$ 366.30M$ 326.66M$ 345.87M$ 353.16M$ 250.98M
Operating Expenses
$ 367.58M$ 314.13M$ 323.57M$ 280.94M$ 224.28M
Depreciation and Amortization
$ 17.03M$ 23.45M$ 18.03M$ 16.68M$ 8.18M
EBITDA
$ 15.76M$ 36.03M$ 40.32M$ 87.00M$ 37.23M
Operating Income
$ -1.28M$ 12.53M$ 22.30M$ 72.22M$ 26.70M
Other Income/Expenses
$ -1.52M$ -2.13M$ -2.02M$ -9.13M$ -8.94M
Pretax Income
$ -2.81M$ 10.39M$ 20.28M$ 63.09M$ 17.76M
Net Income
$ 861.00K$ 4.95M$ 15.53M$ 94.20M$ 17.23M
Per Share Metrics
Basic EPS
$ 0.01$ 0.04$ 0.12$ 0.73$ 0.16
Diluted EPS
$ 0.01$ 0.04$ 0.12$ 0.70$ 0.15
Weighted Average Shares Outstanding
131.67M 131.23M 130.07M 128.33M 107.74M
Weighted Average Shares Outstanding (Diluted)
131.67M 132.75M 132.38M 133.66M 111.36M
Currency in USD

Organogenesis Holdings Earnings and Revenue History